Envestnet Portfolio Solutions Inc. Sells 4,622 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Envestnet Portfolio Solutions Inc. reduced its position in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 6.9% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 62,615 shares of the company's stock after selling 4,622 shares during the period. Envestnet Portfolio Solutions Inc. owned about 0.05% of Henry Schein worth $4,289,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently modified their holdings of HSIC. Invesco Ltd. boosted its position in Henry Schein by 0.4% during the fourth quarter. Invesco Ltd. now owns 4,963,409 shares of the company's stock valued at $343,468,000 after purchasing an additional 17,552 shares during the last quarter. FMR LLC boosted its position in Henry Schein by 6.6% during the fourth quarter. FMR LLC now owns 3,498,033 shares of the company's stock valued at $242,064,000 after purchasing an additional 217,143 shares during the last quarter. Geode Capital Management LLC boosted its position in Henry Schein by 0.5% during the fourth quarter. Geode Capital Management LLC now owns 3,169,033 shares of the company's stock valued at $218,762,000 after purchasing an additional 14,876 shares during the last quarter. Palestra Capital Management LLC acquired a new position in Henry Schein during the fourth quarter valued at approximately $182,988,000. Finally, Fiduciary Management Inc. WI boosted its position in Henry Schein by 7.2% during the fourth quarter. Fiduciary Management Inc. WI now owns 2,488,335 shares of the company's stock valued at $172,193,000 after purchasing an additional 167,990 shares during the last quarter. 96.62% of the stock is owned by institutional investors and hedge funds.

Henry Schein Stock Performance

Shares of NASDAQ HSIC traded down $0.09 during trading hours on Monday, reaching $71.89. 1,890,683 shares of the stock were exchanged, compared to its average volume of 1,707,971. The firm has a market capitalization of $8.75 billion, a price-to-earnings ratio of 15.03, a P/E/G ratio of 2.32 and a beta of 0.86. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.75 and a current ratio of 1.38. Henry Schein, Inc. has a 52 week low of $60.56 and a 52 week high of $82.49. The stock's fifty day simple moving average is $68.94 and its 200 day simple moving average is $71.24.

Henry Schein (NASDAQ:HSIC - Get Free Report) last announced its earnings results on Monday, May 5th. The company reported $1.15 earnings per share for the quarter, topping analysts' consensus estimates of $1.11 by $0.04. The company had revenue of $3.17 billion for the quarter, compared to analyst estimates of $3.24 billion. Henry Schein had a return on equity of 14.87% and a net margin of 3.21%. The firm's quarterly revenue was down .1% compared to the same quarter last year. During the same quarter last year, the company earned $1.10 earnings per share. Sell-side analysts predict that Henry Schein, Inc. will post 4.74 EPS for the current year.

Analyst Ratings Changes

Several research analysts recently commented on HSIC shares. Wells Fargo & Company reduced their price target on Henry Schein from $80.00 to $75.00 and set an "equal weight" rating for the company in a research report on Tuesday, May 6th. Piper Sandler dropped their price objective on Henry Schein from $83.00 to $77.00 and set an "overweight" rating on the stock in a research note on Wednesday, April 30th. UBS Group dropped their price objective on Henry Schein from $83.00 to $80.00 and set a "neutral" rating on the stock in a research note on Wednesday, February 26th. Barrington Research dropped their price objective on Henry Schein from $90.00 to $86.00 and set an "outperform" rating on the stock in a research note on Tuesday, May 6th. Finally, Wall Street Zen lowered Henry Schein from a "buy" rating to a "hold" rating in a research note on Thursday, April 17th. Six analysts have rated the stock with a hold rating, five have given a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $79.30.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.